Skip to content
Malta's world news feed Local perspective with global outlook
CDE.NEWS The Dispatch
Coronavirus

EU regulator backs month-long storage of Pfizer COVID-19 vaccine in fridges

epa08905048 Health workers prepare for vaccination with a vaccine of the Pfizer-BioNTech against the COVID-19 at the faculty hospital in Nitra, Slovakia, 26 December 2020. Slovakia started with vaccination in the evening on 26 December 2020. Some 12.5 million doses of the vaccine are being shipped to European countries after the European Medicines Agency (EMA) gave the green light to European countries to start COVID-19 vaccinations in the coming days using shot jointly developed by US company Pfizer and its German partner BioNTech. EPA-EFE/STRINGER

Europe’s drug regulator on Monday recommended extending the storage time for the Pfizer-BioNTech COVID-19 vaccine at normal fridge temperatures to 31 days from five days, easing logistical challenges during rollouts in the region.

The change is applicable to unopened vials, the European Medicines Agency (EMA) said, adding that the advice by its human medicines committee came after assessing additional stability study data submitted by Pfizer and BioNTech.

“EMA is in continuous dialogue with the marketing authorisation holders of COVID-19 vaccines as they seek to make manufacturing improvements to enhance vaccine distribution in the EU,” the watchdog said.

The EU has allowed for ramped-up production of the Pfizer-BioNTech vaccine in the region and is eyeing a new deal to secure more doses of the shot after the bloc was hit by cuts in the supply of AstraZeneca’s vaccine.

Vaccine deliveries were also slower initially under the EU’s centralised procurement strategy.

U.S. authorities in February had approved storage and transport of the Pfizer-BioNTech vaccine at standard freezer temperatures of -15 to -25 degrees Celsius for up to two weeks instead of the ultra-cold temperatures between -80 to -60 degrees Celsius it usually requires.

via Reuters

Filed under Comuniq.EUCoronavirus
Topics Pfizer

More from Coronavirus

More →